首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncogene

缩写:ONCOGENE

ISSN:0950-9232

e-ISSN:1476-5594

IF/分区:7.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引9654
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ming Feng,Wenrui He,Guoxiao Ji et al. Ming Feng et al.
Despite significant advances in colorectal cancer (CRC) diagnosis and treatment, drug therapy of CRC patients is still confronted with considerable challenges. Carbohydrate response element-binding protein (ChREBP), a glucose-responsive tra...
Brittany N Heil,Garima Baral,Claire M Pfeffer et al. Brittany N Heil et al.
Lung cancer is the leading cause of cancer-related deaths in the United States, and ~50% of these patients present with metastatic disease at diagnosis. Epithelial-to-Mesenchymal Transition (EMT) is an important initiating step in the metas...
Eunjin Jeong,Hye Lin Kim,Seohee Park et al. Eunjin Jeong et al.
HECT and RCC1-like domain-containing protein 1 (HERC1), a large E3 ubiquitin ligase, has been implicated in neural development and genome stability, but its role in cancer remains unclear. This study identifies HERC1 as a critical regulator...
Moon Hee Yang,Shikha Sheth,Bing Shui et al. Moon Hee Yang et al.
K-Ras represents one of the most frequently mutated and therapeutically relevant oncogenic drivers. Clinical and epidemiological data suggest association between specific KRAS alleles, therapeutic responses, and patient outcomes, however, d...
Ashok Bharathy Mariappan Ragupathi,Chi V Dang,Daniel J Zabransky Ashok Bharathy Mariappan Ragupathi
The Wnt (Wingless/Integrated) signaling pathway is a highly conserved regulator of development, stem cell maintenance, and tissue homeostasis. Its dysregulation is a hallmark of cancer, driving uncontrolled proliferation, epithelial-mesench...
Zhiyuan Shen,Yuexing Yang,Tianyu Mao et al. Zhiyuan Shen et al.
Cancer-associated hyperfibrinolysis are potentially fatal outcomes of advanced cancer. Unfortunately, this knowledge has not yet led to any breakthrough in cancer therapy. Plasmin is the key enzyme of fibrinolytic system. The identification...
Zi-Zhan Li,Cheng-Ke Zhou,Zhi-Jun Sun Zi-Zhan Li
Cancer remains a leading cause of human mortality worldwide, imposing a substantial public health burden. A deep understanding of the tumor microenvironment (TME) is essential for improving cancer care. Erythroid progenitor cells (EPCs) wer...
Hui Chen,Xinyang Hu,Lifeng Feng et al. Hui Chen et al.
Protein post-translational modifications are crucial in driving cancer development and progression. The SUMO E3 ligase PIAS4 regulates various cellular processes, thereby promoting tumour advancement. However, the role of PIAS4 in breast ca...
Qinlian Jiao,Yidan Ren,Xin Su et al. Qinlian Jiao et al.
The clinical application of targeted therapy and immune checkpoint inhibitors (ICIs) has significantly improved the survival prognosis of patients with hepatocellular carcinoma (HCC). However, due to the high heterogeneity of HCC, the respo...
Guangyu Sun,Shuaiqi Chen,Mingzhe Chen et al. Guangyu Sun et al.
Prostate cancer is the most common malignant tumor among men worldwide, severely threatening the health of aging males. RNA 5-methylcytosine (m5C) modification has been demonstrated to play a significant role in the initiation and progressi...